Literature DB >> 467595

The effect of piroxicam on platelet aggregation.

B J Gaynor, J W Constantine.   

Abstract

Piroxicam inhibited aggregation of human and dog platelets caused by collagen, but not by adenosine diphosphate (ADP). Release of platelet ADP was inhibited by piroxicam.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 467595     DOI: 10.1007/bf01968256

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  20 in total

1.  AGGREGATION OF RABBIT BLOOD PLATELETS PRODUCED IN VITRO BY SALINE "EXTRACT" OF TENDONS.

Authors:  T HOVIG
Journal:  Thromb Diath Haemorrh       Date:  1963-07-15

2.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

3.  Inhibition of platelet aggregation and of experimental thrombosis by sudoxicam.

Authors:  J W Constantine; I M Purcell
Journal:  J Pharmacol Exp Ther       Date:  1973-12       Impact factor: 4.030

4.  Effect of a new anti-inflammatory drug, fenoprofen, on platelet aggregation and thrombus formation.

Authors:  R G Herrmann; W S Marshall; V G Crowe; J D Frank; D L Marlett; W B Lacefield
Journal:  Proc Soc Exp Biol Med       Date:  1972-02

5.  Acetylsalicylic acid: inhibition of platelet aggregation in the rabbit.

Authors:  F J Rosenberg; P E Gimber-Phillips; G E Groblewski; C Davison; D K Phillips; S J Goralnick; E D Cahill
Journal:  J Pharmacol Exp Ther       Date:  1971-11       Impact factor: 4.030

Review 6.  Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.

Authors:  H J Weiss
Journal:  Am Heart J       Date:  1976-07       Impact factor: 4.749

7.  Temperature and the aggregation of rabbit platelets by adenosine diphosphate.

Authors:  J W Constantine
Journal:  Nature       Date:  1965-03-13       Impact factor: 49.962

8.  Aggregation and adhesion of rat platelets.

Authors:  J W Constantine
Journal:  Nature       Date:  1967-06-10       Impact factor: 49.962

9.  Piroxicam, a novel anti-inflammatory agent.

Authors:  E H Wiseman; Y H Chang; J G Lombardino
Journal:  Arzneimittelforschung       Date:  1976

10.  Thrombosis prevention by acetylsalicylic acid in hyperlipemic rats.

Authors:  S Renaud; J Godu
Journal:  Can Med Assoc J       Date:  1970-11-07       Impact factor: 8.262

View more
  4 in total

Review 1.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

Review 2.  Piroxicam: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

3.  Serum concentration of piroxicam and inhibition of platelet aggregation in patients with rheumatoid arthritis and M. Bechterew.

Authors:  R Koytchev; R G Alken; E Gromnica-Ihle
Journal:  Agents Actions       Date:  1994-11

Review 4.  Piroxicam-β-cyclodextrin: a GI safer piroxicam.

Authors:  C Scarpignato
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.